-
Discovery Labs' Aerosolized KL4 Surfactant Significantly Improves Lung Function and Survival in Established Model of Acute Lung Injury (DSCO)
Tuesday, May 3, 2011 - 7:24am | 71Discovery Laboratories (Nasdaq: DSCO), announced that new data from a study using aerosolized KL4 surfactant demonstrated a significant improvement in lung function and survival when treating Acute Lung Injury in a well-established preclinical model of this severe respiratory condition. The study...
-
Pfizer Guides FY 2012 EPS $2.25-2.35 vs. $2.28 Est.; Revenues $62.2-64.7V vs. $62.92B Est. (PFE)
Tuesday, May 3, 2011 - 7:20am | 23Pfizer (NYSE: PFE) Guides FY 2012 EPS $2.25-2.35 vs. $2.28 Est.; Revenues $62.2-64.7V vs. $62.92B Est.
-
Pfizer Guides Fy 2011 EPS $2.16-2.26 vs. $2.24 Est.; Revenues $65.2-67.2B vs. $66.89B Est. (PFE)
Tuesday, May 3, 2011 - 7:19am | 23Pfizer (NYSE: PFE) Guides Fy 2011 EPS $2.16-2.26 vs. $2.24 Est.; Revenues $65.2-67.2B vs. $66.89B Est.
-
Pfizer Sees Buying Back $5B-$7B Stock this Year (PFE)
Tuesday, May 3, 2011 - 7:17am | 20Pfizer (NYSE: PFE) sees buying back $5B-$7B of stock this year.
-
Pfizer Reports EPS of $0.60 vs. $0.59 Estimate; Revenues $16.5B vs. $16.65B Estimate (PFE)
Tuesday, May 3, 2011 - 7:00am | 21Pfizer (NYSE: PFE) Reports EPS of $0.60 vs. $0.59 Estimate; Revenues $16.5B vs. $16.65B Estimate
-
JP Morgan Raises PT on BioMimetic Therapeutics to $17
Tuesday, May 3, 2011 - 6:25am | 27JP Morgan has raised the price target on BioMimetic Therapeutics (NASDAQ: BMTI) from $16 to $17 and maintains its Overweight rating.
-
US Stock Futures Down As Investors Await Pfizer Earnings, Factory Orders Data
Tuesday, May 3, 2011 - 6:18am | 568US stock futures are lower this morning, as investors are awaiting earnings from Pfizer Inc (NYSE: PFE) and report on factory orders. Futures on the Dow Jones Industrial Average dipped 40 points to 12,724.00 and futures on the S&P 500 stock index fell 5.20 points to 1,352.50. Nasdaq 100 futures...
-
Earnings Preview for Pfizer (PFE)
Tuesday, May 3, 2011 - 5:11am | 143Pfizer (NYSE: PFE) is presenting its Q1 earnings on Tuesday before the bell. Analysts are expecting earnings of $0.58 per share, which is 2.17% higher than the same period last year. Shares of Pfizer are currently trading at $21.02, which is just below their 52-week high of $21.20 set on May 2nd....
-
Earnings Preview For Allergan (AGN, MRK, ISPH, VRX, CEPH)
Tuesday, May 3, 2011 - 4:25am | 456Allergan is expected to announce its Q1 earnings results on Wednesday, May 4, before the markets open. Analysts are predicting earnings per share to reach $0.74, up 13.8% on the last year's level of $0.65. Within the last 60 days, consensus estimate was lowered by $0.01. Revenues are projected to...
-
Earnings Scheduled For May 3 (LM, MA, LVS, AVP, PFE, UNM, AMT, CBS, THC, CTSH, MCK, CLX, DUK, MRO, CMCSA, PCS, MYL, FWLT, TAP, ADM, EMR)
Tuesday, May 3, 2011 - 12:43am | 558Legg Mason Inc (NYSE: LM) is expected to report its Q4 EPS at $0.45 on revenue of $712.27 million. Mastercard Incorporated (NYSE: MA) is projected to report its Q1 EPS at $4.10 on revenue of $1.46 billion. Las Vegas Sands Corp (NYSE: LVS) is expected to report its Q1 EPS at $0.44 on revenue of...
-
Top 4 Large-Cap Stocks In The Drug Manufacturers-Major Industry With The Lowest PEG Ratio (GSK, ABT, MRK, JNJ)
Tuesday, May 3, 2011 - 12:38am | 118Below are the top large-cap drug manufacturers-major stocks on the NYSE and the NASDAQ in terms of PEG ratio GlaxoSmithKline plc (NYSE: GSK) has a PEG ratio of 0.72. GSK's trailing-twelve-month operating margin is 32.51%. Abbott Laboratories (NYSE: ABT) has a PEG ratio of 1.26. ABT's trailing-...
-
Stocks To Watch For May 3 (MA, APC, PFE, CHK, CBS)
Tuesday, May 3, 2011 - 12:35am | 281Some of the stocks that may grab investor focus today are: Wall Street expects Mastercard Incorporated (NYSE: MA) to report its Q1 EPS at $4.10 on revenue of $1.46 billion. MA shares gained 0.04% to $275.40 in after-hours trading. Anadarko Petroleum Corp (NYSE: APC) reported its Q1 net income at...
-
Fast Money Picks For May 3rd (TEVA, HON, NM, EPU, SBUX)
Monday, May 2, 2011 - 9:50pm | 263On CNBC's Fast Money, Anthony Scaramucci said that he likes Teva Pharmaceutical Industries Ltd (ADR) (NASDAQ: TEVA). This stock was the hedge fund trade of the week last week. Teva Pharmaceutical Industries Ltd (ADR) (TEVA) gained 3.37%, and it closed at $47.27. Tim Seymour likes iShares MSCI All...
-
Integrating Options into "Sell in May & Go Away" 05-02-2011
Monday, May 2, 2011 - 6:31pm | 904Cusick's Corner What I do not like about the short-term action is that the market has been unable to hold the gains that we started off with and that we have had almost a week of indecision. Could this be the May syndrome of "Sell in May and Go Away"? If you sell in May and come back in September...
-
Tuesday's Stocks to Watch and Trading Ideas
Monday, May 2, 2011 - 5:35pm | 2446( click to enlarge ) Downward bias in Valeant Pharmaceuticals Int (NYSE:VRX). The stock broke support of $51.15 today on above average volume. Short term momentum indicators, like MACD, RSI and Stochastics are also in Bearish areas. A decline to its 50-day moving average currently at $46.13...